Related Experiment Video
Updated: Jan 13, 2026

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
Parkinson's disease-specific α-Synuclein variants potentially drive Lewy body formation by engaging in promiscuous
Sneha Jos1, Niharika Shivanandaswamy1, Akshya Sharma2
1Department of Biophysics, National Institute of Mental Health and Neurosciences, Bengaluru, India.
Abstract:
Lewy bodies (LBs), a pathological hallmark of synucleinopathies, are heterogeneous inclusions that contain α-Synuclein (αSyn) alongside numerous proteins, lipids, and damaged organelles. Current αSyn-fibrillization centric aggregation/phase separation models fail to explain how diverse cellular components are sequestered by disease-specific αSyn variants during LB formation. In the crowded intracellular milieu, proteins constantly encounter one another, but functional protein-protein interactions must outweigh disease-causing 'hydrophobicity' driven non-functional interactions. Although αSyn wild-type (WT) has a hydrophobic (NAC) core, it is shielded by long-range intramolecular interactions, rendering it "inert." In contrast, Parkinson's disease (PD)-specific αSyn variants-S129 phosphorylation and C-terminal truncations-aggregate and phase separate more rapidly, suggesting hydrophobic exposure. We hypothesize that exposed hydrophobic core in PD-specific αSyn variants not only drives aggregation and phase separation but also promotes promiscuous, non-functional binding to diverse proteins. Using various biochemical and biophysical approaches, we demonstrate that αSynWT engages in functional interactions, whereas C-terminal acidic tail truncated αSyn1-103 and S129-phosphomimicking (S129E) mutant are "reactive," displaying broad, non-functional aberrant binding and impairing chaperone-mediated refolding. Based on our study, we propose a 'Multifactorial Random Disorder Model' outlining how PD-specific αSyn variants drive LB formation through non-functional heterotypic interactions.
Related Concept Videos
Parkinson's Disease: Overview
Neural Regulation
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Lysosomal Hydrolases
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

